SEC Form 4 · accession 0001513162-18-000253
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arnold M Baskies
Director
Period of report
Oct 8, 2018
Accepted (ET)
Oct 9, 2018 · 7:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1,F2 | $5.29 | Oct 8, 2018 | A | 45,000 | A | — | Oct 8, 2028 | Common Stock | 45,000 | 45,000 | D |
Explanation of responses
- F1Right-To-Buy, granted under the Anixa Biosciences, Inc. 2010 Share Incentive Plan.
- F2The options vest and become exercisable in twelve (12) equal monthly installments beginning October 31, 2018.